Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Erythropoietin on Hematological Adaptations and Physical Performance
NCT05078138Phase 4Completed
- Sponsor
- U.S. Army Research Institute of Environmental Medicine
- Start
- Sep 2021
- Primary completion
- Apr 2023
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 4 trial of epoetin alfa in anemia, sponsored by U.S. Army Research Institute of Environmental Medicine. Started Sep 2021; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT05078138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05078138.